Varenicline Tablet, Film Coated
Product Images NDC 70518-4647

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 70518-4647). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description for a Varenicline tablet with a strength of 0.5 mg. The tablet is repackaged by RemedyRepack Inc. The manufacturer's NDC is 31722-0678-56 and is manufactured by Camber Pharma, Inc. The prescription medication is for exclusive use in Indiana, PA. The usual dosage information can be found in the insert provided. It should be stored at a temperature range of 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F) as per USP guidelines.*

FDA Label Image

Vareniclinecamberlogo (Vareniclinecamberlogo)

FDA Label Image

Vareniclinefigure1 (Vareniclinefigure1)

FDA Label Image

Vareniclinefigure2 (Vareniclinefigure2)

FDA Label Image

Vareniclinefigure3 (Vareniclinefigure3)

This appears to be a graph or table showing some sort of treatment comparison between Varenicline 1.0 mg BID and Placebo. The x-axis seems to represent the weeks of nontreatment follow-up, while the y-axis or data points might indicate some kind of continuous abstinent percentage. Additional information and context may be needed to provide a more precise interpretation of the data presented.*

FDA Label Image

Vareniclinestructure (Vareniclinestructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.